What's Going to Be Hot at ESC 2022?
DELIVER, testing dapagliflozin in HFpEF, is a big draw, but there’s also buzz for REVIVED, INVICTUS, and early-stage drug trials.
Source: tctmd.com
Stay updated with breaking news from Clinical Program Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DELIVER, testing dapagliflozin in HFpEF, is a big draw, but there’s also buzz for REVIVED, INVICTUS, and early-stage drug trials.